Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	133.58	121.18	99.8	39.73	2.9	5.04
Cash & Short-Term Investments	133.58	121.18	99.8	39.73	2.9	5.04
Cash Growth	-25.93%	21.41%	151.21%	1271.89%	-42.59%	299.07%
Accounts Receivable	41.9	87.67	245.13	301.87	74.01	97.48
Other Receivables	-	193.25	64.67	82.3	-	-
Receivables	93.9	383.22	329.59	406.95	99.5	132.1
Inventory	158.96	99.53	23.14	31.57	39.54	16.82
Prepaid Expenses	-	0.11	0.17	0.22	0.59	0.31
Other Current Assets	277.22	50.24	109.62	52.25	16.2	6.33
Total Current Assets	663.66	654.27	562.33	530.72	158.72	160.6
Property, Plant & Equipment	208.67	213.43	216.05	218.95	192.41	193.53
Long-Term Investments	-	-	-	-	-	1.95
Total Assets	872.34	867.7	778.37	749.66	351.13	356.08
Accounts Payable	82.75	92.16	72.21	336.22	85.9	53.29
Accrued Expenses	-	15.37	10.81	9.18	10.33	7.83
Current Portion of Long-Term Debt	10.78	10.64	4.97	13.13	2.5	-
Current Unearned Revenue	-	26.44	35.28	66.12	24.68	8.45
Other Current Liabilities	80.93	28.22	18.25	0.42	0.36	0.78
Total Current Liabilities	174.46	172.84	141.53	425.06	123.77	70.35
Long-Term Debt	26.78	31.13	26.57	37.68	31.27	97.71
Pension & Post-Retirement Benefits	1.35	1.27	1.15	1.08	-	-
Long-Term Deferred Tax Liabilities	11.69	34.11	32.73	32.87	32.6	32.03
Other Long-Term Liabilities	-	-	-	-0	-0	-
Total Liabilities	214.28	239.34	201.98	496.7	187.63	200.09
Common Stock	437.88	437.88	109.47	39.14	15.66	15.66
Additional Paid-In Capital	-	47.4	91.19	22.79	-	-
Retained Earnings	-	143	375.66	191.13	147.84	140.34
Comprehensive Income & Other	220.18	0.08	0.08	-0.09	-	-
Shareholders' Equity	658.06	628.36	576.4	252.97	163.5	155.99
Total Liabilities & Equity	872.34	867.7	778.37	749.66	351.13	356.08
Total Debt	37.56	41.77	31.54	50.82	33.77	97.71
Net Cash (Debt)	96.02	79.41	68.27	-11.09	-30.87	-92.66
Net Cash Growth	-37.28%	16.33%	-	-	-	-
Net Cash Per Share	0.15	0.18	0.16	-0.16	-0.49	-1.48
Filing Date Shares Outstanding	475.62	437.88	438.39	438.39	62.63	62.63
Total Common Shares Outstanding	475.62	437.88	438.39	438.39	62.63	62.63
Working Capital	489.2	481.44	420.79	105.66	34.95	90.25
Book Value Per Share	1.38	1.44	1.31	0.58	2.61	2.49
Tangible Book Value	658.06	628.36	576.4	252.97	163.5	155.99
Tangible Book Value Per Share	1.38	1.44	1.31	0.58	2.61	2.49
Land	-	1.72	1.72	1.72	1.7	1.72
Buildings	-	125.26	125.26	116.73	100.5	100.4
Machinery	-	307.27	282.68	277.22	248.6	233.14
Construction In Progress	-	19.45	16.62	16.62	16.62	16.62

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.